Apple accounted for roughly 90% of all Edge AI-capable smartwatch shipments in the first quarter of 2026. The Edge AI smartwatch market grew 70% year-over-year, reaching 25% penetration of the overall smartwatch market, meaning one in four smartwatches shipped in Q1 2026 now includes on-device AI processing capability, according to Counterpoint Research.
Apple Watch shipments themselves surged 21% year-over-year in Q1, pushing the brand’s overall smartwatch market share to 23%. By contrast, Samsung’s shipments plunged 28%, while Huawei held 17% market share and Xiaomi 9%. North America accounted for more than half of Apple’s shipments, though China and Europe recorded the fastest growth for the brand. The broader smartwatch market grew just 4% year-on-year during the same period, underscoring Apple’s outsize advantage in the Edge AI subcategory.
What Edge AI on Smartwatches Actually Does
Edge AI refers to processing artificial intelligence tasks locally on a device rather than sending data to cloud servers. For the Apple Watch, this means the Neural Engine built into the device handles gesture recognition, voice processing for Siri, and certain health and safety signals without relying on network connectivity or external servers. Local processing enables faster responses, offline functionality, and improved privacy since sensitive health data remains on the device.
Mohit Agrawal, Research Director at Counterpoint Research, characterized the inflection point: “Edge AI in smartwatches is shifting from primarily a hardware integration to one that also includes software optimization. The real unlock is smaller, more efficient models and OS-level access that lets any app run inference locally. AI needs to turn from a single application into a personal layer that works on personal data.” This distinction explains why Apple’s tight integration of watchOS and hardware translates into such dominance: competitors lack both the optimized silicon and the OS-level control to deliver the same experience.
Health Monitoring Capabilities Accelerate
The most striking development in Q1 2026 was the expansion of advanced health features. Smartwatches with blood pressure monitoring doubled in shipments during the quarter, while those offering sleep apnea detection tripled. These are not cosmetic additions but clinically relevant capabilities that position the smartwatch as a genuine health monitoring device rather than a fitness tracker accessory.
Apple Watch accounted for nearly all of these shipments. The company has steadily expanded health features powered by on-device AI, and the Edge AI capability amplifies this advantage: local processing means real-time analysis of heart rhythms, sleep patterns, and other biometric data without the latency or privacy concerns of cloud-based analysis. For a consumer concerned about atrial fibrillation or sleep apnea, the difference between on-device detection and cloud-processed alerts is the difference between useful and potentially dangerous.
Why Competitors Cannot Catch Up
Samsung’s 28% shipment decline despite the broader smartwatch market growing points to a structural gap in product capability. Samsung does not control its own silicon at the smartwatch level the way Apple does; it relies on third-party chipmakers and lacks the same OS-level integration. Huawei and Xiaomi have made gains in certain markets, but neither has the ecosystem depth or the AI optimization footprint to match Apple’s offerings.
The memory cost pressures affecting the broader tech industry have minimal impact on smartwatches given their lower bill of materials, so the usual excuse for competitor struggles does not apply here. Apple’s dominance reflects product execution, hardware-software integration, and brand strength in health-conscious segments where the Apple Watch has become quasi-essential for iOS users.
What Comes Next
Counterpoint projects Edge AI penetration in smartwatches will reach 32% by the end of 2026, up from 25% in Q1. The broader smartwatch market is expected to grow just 1% for the full year, but Apple is forecast to outpace the category, buoyed by the full-year availability of the Apple Watch Ultra 3 and Apple Watch SE 3. The portfolio breadth matters: the SE at a lower price point captures price-sensitive buyers, while the Ultra targets serious athletes and users who demand the most advanced health features.
By 2027, the question will not be whether a smartwatch has local AI processing but what it can do with it. Apple’s dominance in meaningful Edge AI health features gives it an enormous lead that competitors cannot close through chipset improvements alone. Software matters more than hardware at this stage, and Apple controls both.
